We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,406
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHBI icon
7126
Shore Bancshares
SHBI
$790M
$743K ﹤0.01%
+70,617
New +$803K
CMPR icon
7127
Cimpress
CMPR
$2.18B
$743K ﹤0.01%
10,608
-11,666
-52% -$772K
MYGN icon
7128
CALL
Myriad Genetics
MYGN
$275M
$743K ﹤0.01%
46,300
+30,100
+186% +$573K
WUGI icon
7129
AXS Esoterica NextG Economy ETF
WUGI
$31.9M
$742K ﹤0.01%
+16,661
New +$781K
ESI icon
7130
Element Solutions
ESI
$9.09B
$742K ﹤0.01%
37,844
-109,809
-74% -$2.18M
ACRS icon
7131
PUT
Aclaris Therapeutics
ACRS
$927M
$742K ﹤0.01%
108,300
+21,900
+25% +$187K
VGIT icon
7132
Vanguard Intermediate-Term Treasury ETF
VGIT
$42.4B
$741K ﹤0.01%
12,974
+12,535
+2,855% +$727K
XPOF icon
7133
PUT
Xponential Fitness
XPOF
$214M
$741K ﹤0.01%
47,800
-25,800
-35% -$506K
MMI icon
7134
Marcus & Millichap
MMI
$1.2B
$741K ﹤0.01%
25,243
-6,703
-21% -$224K
FLWS icon
7135
PUT
1-800-Flowers.com
FLWS
$258M
$741K ﹤0.01%
105,800
+73,400
+227% +$551K
OSCR icon
7136
CALL
Oscar Health
OSCR
$9.65B
$740K ﹤0.01%
132,900
-15,500
-10% -$108K
ORTX
7137
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$739K ﹤0.01%
95,272
-30,249
-24% -$164K
GABC icon
7138
German American Bancorp
GABC
$1.91B
$739K ﹤0.01%
+27,266
New +$779K
SQLV icon
7139
Royce Quant Small-Cap Quality Value ETF
SQLV
$40.9M
$738K ﹤0.01%
+20,517
New +$763K
ALE
7140
DELISTED
Allete
ALE
$738K ﹤0.01%
13,980
-47,904
-77% -$2.7M
PRG icon
7141
PUT
PROG Holdings
PRG
$1.65B
$737K ﹤0.01%
22,200
-1,300
-6% -$45.3K
QGEN icon
7142
PUT
Qiagen
QGEN
$8.74B
$737K ﹤0.01%
17,164
+15,278
+810% +$712K
LU icon
7143
Lufax Holding
LU
$1.33B
$736K ﹤0.01%
173,580
-1,252,392
-88% -$6.94M
AY
7144
CALL
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$735K ﹤0.01%
38,500
-2,200
-5% -$49.8K
NEU icon
7145
NewMarket
NEU
$8.71B
$735K ﹤0.01%
1,616
-3,367
-68% -$1.52M
XYLD icon
7146
PUT
Global X S&P 500 Covered Call ETF
XYLD
$3.29B
$735K ﹤0.01%
18,900
+17,800
+1,618% +$721K
SNY icon
7147
Sanofi
SNY
$108B
$735K ﹤0.01%
13,699
+13,508
+7,072% +$720K
IMXI icon
7148
International Money Express
IMXI
$439M
$735K ﹤0.01%
43,398
-97,839
-69% -$1.97M
WTTR icon
7149
CALL
Select Water Solutions
WTTR
$2.72B
$734K ﹤0.01%
92,300
-49,500
-35% -$407K
AGG icon
7150
PUT
iShares Core US Aggregate Bond ETF
AGG
$138B
$734K ﹤0.01%
7,800
+6,000
+333% +$578K

Similar funds

Ken Griffin's Q3 2023 Portfolio in Review

As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
  • Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.